(Q43248722)

17 November 2017

title

Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres (English)

1 reference

17 November 2017

1 reference

1 reference

Sanjay G Gayakwad

1

1 reference

17 November 2017

Naveen K Bejugam

2

1 reference

17 November 2017

Nima Akhavein

3

1 reference

17 November 2017

Nasir A Uddin

4

1 reference

17 November 2017

Carl E Oettinger

5

1 reference

17 November 2017

Martin J D'Souza

6

1 reference

17 November 2017

publication date

1 December 2009

1 reference

Journal of Microencapsulation

17 November 2017

published in

1 reference

17 November 2017

volume

26

1 reference

17 November 2017

issue

8

1 reference

17 November 2017

page(s)

692-700

1 reference

Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Effects of steroid treatment on activation of nuclear factor kappaB in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Oligonucleotides in the treatment of leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Increased synovial tissue NF-kappa B1 expression at sites adjacent to the cartilage-pannus junction in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Progress in antisense oligonucleotide therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Treatment of experimental septic shock with microencapsulated antisense oligomers to NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Inhibition of nuclear factor kappa B (NF-B): an emerging theme in anti-inflammatory therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Polymer microspheres for controlled drug release

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Missing pieces in the NF-kappaB puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

In vitro evaluation and targeting of . coli internalized by endothelial cells using albumin microspheres loaded with gentamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

The cellular delivery of antisense oligonucleotides and ribozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Antisense therapy for cancer--the time of truth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Albumin microspheres as vehicles for the sustained and controlled release of doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Cellular delivery of antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Preparation and characterisation of rose Bengal-loaded surface-modified albumin nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

In vitro antimicrobial effect of encapsulated vancomycin on internalized Staphylococcus aureus within endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Pro-inflammatory cytokine inhibition in the primate using microencapsulated antisense oligomers to NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Spray-drying as a method for microparticulate controlled release systems preparation: advantages and limits. I. Water-soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappaB abrogate fulminant septic shock induced by S. typhimurium in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

NF-kappaB in transplantation: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Pharmaceutical particle engineering via spray drying

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

Control of encapsulation efficiency and initial burst in polymeric microparticle systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02652040802666910

10.3109/02652040802666910

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference